Filing Manager
Cambridge Equities, LP
Reporting Manager
Patrick Soon-Shiong
Symbol
IBRX
Shares outstanding
1,124,549,707 shares
Disclosed Ownership
745,576,456 shares
Ownership
66%
Form type
SCHEDULE 13D/A
Filing time
25 Feb 2026, 21:51:53 UTC
Date of event
23 Feb 2026
Previous filing
10 Nov 2025

Sponsored

Quoteable Key Fact

"Cambridge Equities, LP disclosed 66% ownership in ImmunityBio, Inc. Common Stock, par value $0.0001 per share (IBRX) on 23 Feb 2026."

Quick Takeaways

  • Cambridge Equities, LP filed SCHEDULE 13D/A for ImmunityBio, Inc. Common Stock, par value $0.0001 per share (IBRX).
  • Disclosed ownership: 66%.
  • Date of event: 23 Feb 2026.

What Changed

  • Previous schedule filing date: 10 Nov 2025.
  • Current filing was accepted on 25 Feb 2026, 21:51.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Cambridge Equities, LP 26% 261,705,814 0 261,705,814 /s/ Charles Kenworthy Charles Kenworthy, Manager of MP 13 Ventures, LLC, the General Partner of Cambridge Equities, LP 0001629222
MP 13 Ventures, LLC 26% 261,705,814 0 261,705,814 /s/ Charles Kenworthy Charles Kenworthy, Manager 0001629186
NantWorks, LLC 9.6% 98,535,253 0 98,535,253 /s/ Robert Morse Robert Morse, CFO of NantWorks, LLC 0001675760
Nant Capital, LLC 30% 339,465,529 0 339,465,529 /s/ Charles Kenworthy Charles Kenworthy, Manager of Nant Capital, LLC 0001675758
California Capital Equity, LLC 10% 106,511,412 0 106,511,412 /s/ Charles Kenworthy Charles Kenworthy, Manager of California Capital Equity, LLC 0001517764
Patrick Soon-Shiong 66% 745,576,456 32,275,375 713,301,081 /s/ Patrick Soon-Shiong Patrick Soon-Shiong 0001189020